SCHEMBL669139

SCHEMBL669139

CCc1noc(N(CC)c2cc(C#CC(C)(C)C)sc2C(=O)OC)n1

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CYP2E1 P05181 1/20 0.32
RAF1 P04049 1/20 0.31
NR1I2 O75469 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL669158 0.89 CYP2E1 (0.33) CYP2E1RAF1NR1I2
SCHEMBL669157 0.77 RAF1 (0.37) RAF1
SCHEMBL669934 0.76 RAF1 (0.34) RAF1
SCHEMBL15511306 0.76 CYP2E1 (0.51) CYP2E1NR1I2
SCHEMBL15512298 0.76 CYP2E1 (0.51) CYP2E1NR1I2
SCHEMBL669140 0.76 RAF1 (0.36) RAF1
SCHEMBL15511997 0.75 CYP2E1 (0.45) CYP2E1NR1I2
SCHEMBL15498384 0.75 CYP2E1 (0.45) CYP2E1NR1I2
SCHEMBL668933 0.69 MEN1 (0.38) CYP2E1RAF1NR1I2
SCHEMBL10264822 0.69 TSHR (0.35) CYP2E1RAF1NR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2606041-A2 COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRIDAE VIRAL INFECTIONS Vertex Pharmaceuticals Incorporated (US) 2013-06-26 EP disclosed
WO-2012024363-A2 COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRIDAE VIRAL INFECTIONS VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-02-23 WO disclosed